Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. [electronic resource]
Producer: 20100920Description: 30-9 p. digitalISSN:- 1755-3245
- Animals
- Animals, Newborn
- Cardiotonic Agents -- pharmacology
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Darbepoetin alfa
- Disease Models, Animal
- Endothelial Cells -- drug effects
- Epoetin Alfa
- Erythropoietin -- analogs & derivatives
- Heart Failure -- drug therapy
- Humans
- Male
- Myocytes, Cardiac -- drug effects
- Neovascularization, Physiologic -- drug effects
- Paracrine Communication -- drug effects
- RNA, Messenger -- metabolism
- Rats
- Rats, Inbred F344
- Rats, Sprague-Dawley
- Recombinant Proteins
- Recovery of Function
- STAT3 Transcription Factor -- metabolism
- Stem Cell Transplantation
- Stem Cells -- drug effects
- Time Factors
- Transcription, Genetic -- drug effects
- Up-Regulation
- Vascular Endothelial Growth Factor A -- genetics
- Ventricular Function, Left -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.